Dr Reddy's Laboratories Ltd

DRREDDY
Health CarePharmaceuticals
LargecapWith a market cap of ₹76,188 cr, stock is ranked 65
Low RiskStock is 1.58x as volatile as Nifty
4,591.5593.40 (-1.99%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
LargecapWith a market cap of ₹76,188 cr, stock is ranked 65
Low RiskStock is 1.58x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
39.04
PB RatioPB Ratio
4.32
Dividend YieldDiv. Yield
0.55%
Sector PESector PE
37.99
Sector PBSector PB
5.06
Sector Div YldSctr Div Yld
0.68%

Forecast & RatingsDetailed Forecast 

84%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines.

Brands

Dr.Reddy's

Pharmaceutical company

Brands

Dr.Reddy's

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

201820192020202114.4415.8318.1919.390.951.952.031.95
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

ESOP/ESOS/ESPS 
Announced OnJan 18, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 5330 Options. | Download

Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 5330 Options. | Download

Press Release 
Announced OnJan 17, 2022

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 17, 2022, titled "Earnings call ". | Download

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 17, 2022, titled "Earnings call ". | Download

Cash Dividend 
Ex. DateJul 9, 2021

Final • Div/Share: ₹ 25

See all events